Weerkamp et al [11] developed a flow cytometric immunobead assay (FCBA) for the detection of BCR-ABL1 fusion proteins in cell lysates, using a bead-bound anti-BCR catching antibody and a fluorochrome-conjugated anti-ABL detection antibody intended for the rapid diagnosis of Philadelphia positive acute lymphoblastic leukemia (ALL). Here, ABL1 is linked to acute lymphoblastic leukemia.